HK1215388A1 - 可吸入藥用組合物和含有該藥用組合物的吸入器裝置 - Google Patents

可吸入藥用組合物和含有該藥用組合物的吸入器裝置

Info

Publication number
HK1215388A1
HK1215388A1 HK16103381.3A HK16103381A HK1215388A1 HK 1215388 A1 HK1215388 A1 HK 1215388A1 HK 16103381 A HK16103381 A HK 16103381A HK 1215388 A1 HK1215388 A1 HK 1215388A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
devices containing
inhaler devices
inhalable pharmaceutical
inhalable
Prior art date
Application number
HK16103381.3A
Other languages
English (en)
Inventor
Yorick Kamlag
Mathias Keil
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1215388A1 publication Critical patent/HK1215388A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
HK16103381.3A 2013-04-29 2016-03-23 可吸入藥用組合物和含有該藥用組合物的吸入器裝置 HK1215388A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13165786 2013-04-29
PCT/EP2014/058613 WO2014177519A1 (en) 2013-04-29 2014-04-28 Inhalable pharmaceutical compositions and the inhaler devices containing them

Publications (1)

Publication Number Publication Date
HK1215388A1 true HK1215388A1 (zh) 2016-08-26

Family

ID=48190326

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16103381.3A HK1215388A1 (zh) 2013-04-29 2016-03-23 可吸入藥用組合物和含有該藥用組合物的吸入器裝置

Country Status (12)

Country Link
US (1) US20160158149A1 (zh)
EP (1) EP2991625A1 (zh)
JP (1) JP2016519123A (zh)
KR (1) KR20160003183A (zh)
CN (1) CN105324107A (zh)
AU (1) AU2014261538A1 (zh)
BR (1) BR112015027017A2 (zh)
HK (1) HK1215388A1 (zh)
MX (1) MX2015015132A (zh)
RU (1) RU2015150970A (zh)
WO (1) WO2014177519A1 (zh)
ZA (1) ZA201507373B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2910697A1 (en) * 2013-04-29 2014-11-06 Sanofi Sa Inhalable pharmaceutical compositions and the inhaler devices containing them
EP3791942A1 (en) * 2014-05-15 2021-03-17 Angel Playing Cards Co., Ltd. Card shooter device and card storage method
CN106267484A (zh) * 2016-08-08 2017-01-04 中山市美捷时包装制品有限公司 一种干粉吸入装置的定量供料机构
WO2018047013A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
WO2018047002A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
WO2019171174A2 (en) 2018-03-07 2019-09-12 St Ip Holding Ag Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and using same
CN113166127A (zh) 2018-09-18 2021-07-23 St知识产权控股公司 4-烷基-5-杂芳基-3h-1,2-二硫杂环戊烯-3-硫酮的旋转异构异构体
TW202200144A (zh) 2020-03-16 2022-01-01 瑞士商Ｓｔ知識產權控股公司 ４—烷基—５—雜芳基—３ｈ—１，２—二硫雜環戊二烯—３—硫酮之旋轉異構異構物
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
GB0015034D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Inhalation device
AR030516A1 (es) * 2000-08-31 2003-08-20 Glaxo Group Ltd Uso de una combinacion de salmeterol y fluticasona
GB0208608D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Composition
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
GB0324918D0 (en) * 2003-10-24 2003-11-26 Glaxo Group Ltd Composition
CA2543482A1 (en) * 2003-10-28 2005-05-19 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
DE102007056263A1 (de) * 2007-11-22 2009-05-28 Siegfried Generics International Ag Dosiervorrichtung zur Inhalierung einer pulverförmigen Substanz
EP2221048A1 (en) * 2009-02-18 2010-08-25 Siegfried Generics International AG Pharmaceutical composition for inhalation
TR201000681A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut İnhalasyon yoluyla alınan kuru toz formülasyonları.
US20130064870A1 (en) * 2010-05-20 2013-03-14 Sun Pharma Advanced Research Company Limited Dry powder inhalation composition

Also Published As

Publication number Publication date
CN105324107A (zh) 2016-02-10
BR112015027017A2 (pt) 2017-07-25
EP2991625A1 (en) 2016-03-09
ZA201507373B (en) 2017-03-29
MX2015015132A (es) 2016-02-18
AU2014261538A1 (en) 2015-12-10
JP2016519123A (ja) 2016-06-30
KR20160003183A (ko) 2016-01-08
US20160158149A1 (en) 2016-06-09
WO2014177519A1 (en) 2014-11-06
RU2015150970A (ru) 2017-06-07
RU2015150970A3 (zh) 2018-03-29

Similar Documents

Publication Publication Date Title
IL282042A (en) Devices and methods for administering multiple units of drug
IL245211A0 (en) an inhaler for the medicine
IL240290A0 (en) History of pyridazinone-amide and pharmaceutical preparations containing them
RU2016118771A3 (en) Co-crystals and pharmaceutical compositions comprising the same
HK1215388A1 (zh) 可吸入藥用組合物和含有該藥用組合物的吸入器裝置
PT3043773T (pt) Composição farmacêutica de dose fixa estável composta por mometasona e olopatadina para administração nasal
HK1215191A1 (zh) 低劑量醫藥組合物
IL243322A0 (en) Method and controlled dose inhaler
IL246045A0 (en) Inhalable drugs
HK1215167A1 (zh) 可吸入藥用組合物和含有該藥用組合物的吸入器裝置
IL240666A0 (en) Pharmaceutical preparations for oral administration and their uses
HK1219691A1 (zh) 醫藥組成物及其用途
HK1220651A1 (zh) 用於吸入藥用物質的元件
ZA201603463B (en) An inhalable medicament
IL245760A0 (en) Inhalation medicine
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same